Evaluation of a Large-Scale Biomedical Data Annotation Initiative
View/ Open
Published Version
https://doi.org/10.1186/1471-2105-10-S9-S10Metadata
Show full item recordCitation
Lacson, Ronilda, Erik Pitzer, Christian Hinske, Pedro Galante, and Lucila Ohno-Machado. 2009. Evaluation of a large-scale biomedical data annotation initiative. BMC Bioinformatics 10(Suppl 9): S10.Abstract
Background: This study describes a large-scale manual re-annotation of data samples in the Gene Expression Omnibus (GEO), using variables and values derived from the National Cancer Institute thesaurus. A framework is described for creating an annotation scheme for various diseases that is flexible, comprehensive, and scalable. The annotation structure is evaluated by measuring coverage and agreement between annotators. Results: There were 12,500 samples annotated with approximately 30 variables, in each of six disease categories – breast cancer, colon cancer, inflammatory bowel disease (IBD), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Type 1 diabetes mellitus (DM). The annotators provided excellent variable coverage, with known values for over 98% of three critical variables: disease state, tissue, and sample type. There was 89% strict inter-annotator agreement and 92% agreement when using semantic and partial similarity measures. Conclusion: We show that it is possible to perform manual re-annotation of a large repository in a reliable manner.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745681/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:4931095
Collections
- HMS Scholarly Articles [17921]
Contact administrator regarding this item (to report mistakes or request changes)